nach oben

Reactions Weekly

Erschienen in:

01.06.2018 | Case report

Rituximab

Mild tranfusion reaction following off-label use of rituximab: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study, a patient [age and sex not stated] was described, who developed mild transfusion reaction following off-label treatment with rituximab for thrombotic microangiopathy (TMA) secondary to systemic lupus erythematosus (SLE) [dosage, route and time to reaction onset not stated]. The patient, who had TMA secondary to SLE, received off-label treatment with rituximab infusion. Subsequently, the patient developed mild transfusion reaction, which improved after decreasing the infusion speed. …

Sun F, et al. TMA secondary to SLE: Rituximab improves overall but not renal survival. Clinical Rheumatology 37: 213-218, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1007/s10067-017-3793-4 - China

Titel: Rituximab
Mild tranfusion reaction following off-label use of rituximab: case report
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48057-0

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Saxagliptin/sitagliptin/vildagliptin

Gemcitabine

Benzathine benzylpenicillin

Prednisone/tocilizumab

Nivolumab

Clozapine